<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Reacties voor Buro op Tilt	</title>
	<atom:link href="https://burooptilt.nl/comments/feed/" rel="self" type="application/rss+xml" />
	<link>https://burooptilt.nl</link>
	<description>Creatief naar een nieuw niveau</description>
	<lastBuildDate>Wed, 01 Jul 2026 08:47:35 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=5.4.19</generator>
	<item>
		<title>
		Reactie op 1e blog bericht door minoxidil pk evidence		</title>
		<link>https://burooptilt.nl/blogbericht/#comment-62</link>

		<dc:creator><![CDATA[minoxidil pk evidence]]></dc:creator>
		<pubDate>Wed, 01 Jul 2026 08:47:35 +0000</pubDate>
		<guid isPermaLink="false">http://burooptilt.nl/?p=1#comment-62</guid>

					<description><![CDATA[&lt;strong&gt;minoxidil pk evidence&lt;/strong&gt;

minoxidil pk evidence]]></description>
			<content:encoded><![CDATA[<p><strong>minoxidil pk evidence</strong></p>
<p>minoxidil pk evidence</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Reactie op 3e blog bericht door minoxidil duration timeline		</title>
		<link>https://burooptilt.nl/3e-blog-bericht/#comment-61</link>

		<dc:creator><![CDATA[minoxidil duration timeline]]></dc:creator>
		<pubDate>Tue, 30 Jun 2026 20:11:48 +0000</pubDate>
		<guid isPermaLink="false">https://burooptilt.nl/?p=195#comment-61</guid>

					<description><![CDATA[&lt;strong&gt;minoxidil duration timeline&lt;/strong&gt;

minoxidil duration timeline]]></description>
			<content:encoded><![CDATA[<p><strong>minoxidil duration timeline</strong></p>
<p>minoxidil duration timeline</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Reactie op 3e blog bericht door minoxidil men’s full overview		</title>
		<link>https://burooptilt.nl/3e-blog-bericht/#comment-60</link>

		<dc:creator><![CDATA[minoxidil men’s full overview]]></dc:creator>
		<pubDate>Tue, 30 Jun 2026 08:57:55 +0000</pubDate>
		<guid isPermaLink="false">https://burooptilt.nl/?p=195#comment-60</guid>

					<description><![CDATA[&lt;strong&gt;minoxidil men’s full overview&lt;/strong&gt;

minoxidil men’s full overview]]></description>
			<content:encoded><![CDATA[<p><strong>minoxidil men’s full overview</strong></p>
<p>minoxidil men’s full overview</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Reactie op 2e blog bericht door minoxidil foam vs liquid performance		</title>
		<link>https://burooptilt.nl/2e-blog-bericht/#comment-59</link>

		<dc:creator><![CDATA[minoxidil foam vs liquid performance]]></dc:creator>
		<pubDate>Mon, 29 Jun 2026 14:07:28 +0000</pubDate>
		<guid isPermaLink="false">https://burooptilt.nl/?p=194#comment-59</guid>

					<description><![CDATA[&lt;strong&gt;minoxidil foam vs liquid performance&lt;/strong&gt;

minoxidil foam vs liquid performance]]></description>
			<content:encoded><![CDATA[<p><strong>minoxidil foam vs liquid performance</strong></p>
<p>minoxidil foam vs liquid performance</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Reactie op 3e blog bericht door minoxidil basic faq		</title>
		<link>https://burooptilt.nl/3e-blog-bericht/#comment-58</link>

		<dc:creator><![CDATA[minoxidil basic faq]]></dc:creator>
		<pubDate>Mon, 29 Jun 2026 09:09:03 +0000</pubDate>
		<guid isPermaLink="false">https://burooptilt.nl/?p=195#comment-58</guid>

					<description><![CDATA[&lt;strong&gt;minoxidil basic faq&lt;/strong&gt;

minoxidil basic faq]]></description>
			<content:encoded><![CDATA[<p><strong>minoxidil basic faq</strong></p>
<p>minoxidil basic faq</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Reactie op 1e blog bericht door minoxidil clinical comparison		</title>
		<link>https://burooptilt.nl/blogbericht/#comment-57</link>

		<dc:creator><![CDATA[minoxidil clinical comparison]]></dc:creator>
		<pubDate>Sun, 28 Jun 2026 21:38:05 +0000</pubDate>
		<guid isPermaLink="false">http://burooptilt.nl/?p=1#comment-57</guid>

					<description><![CDATA[&lt;strong&gt;minoxidil clinical comparison&lt;/strong&gt;

minoxidil clinical comparison]]></description>
			<content:encoded><![CDATA[<p><strong>minoxidil clinical comparison</strong></p>
<p>minoxidil clinical comparison</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Reactie op 4e blog bericht door minoxidil 2% vs 5% results		</title>
		<link>https://burooptilt.nl/4e-blog-bericht/#comment-56</link>

		<dc:creator><![CDATA[minoxidil 2% vs 5% results]]></dc:creator>
		<pubDate>Sun, 28 Jun 2026 09:48:55 +0000</pubDate>
		<guid isPermaLink="false">https://burooptilt.nl/?p=198#comment-56</guid>

					<description><![CDATA[&lt;strong&gt;minoxidil 2% vs 5% results&lt;/strong&gt;

minoxidil 2% vs 5% results]]></description>
			<content:encoded><![CDATA[<p><strong>minoxidil 2% vs 5% results</strong></p>
<p>minoxidil 2% vs 5% results</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Reactie op 1e blog bericht door minoxidil complete resource		</title>
		<link>https://burooptilt.nl/blogbericht/#comment-55</link>

		<dc:creator><![CDATA[minoxidil complete resource]]></dc:creator>
		<pubDate>Sun, 28 Jun 2026 01:42:26 +0000</pubDate>
		<guid isPermaLink="false">http://burooptilt.nl/?p=1#comment-55</guid>

					<description><![CDATA[&lt;strong&gt;minoxidil complete resource&lt;/strong&gt;

minoxidil complete resource]]></description>
			<content:encoded><![CDATA[<p><strong>minoxidil complete resource</strong></p>
<p>minoxidil complete resource</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Reactie op 3e blog bericht door ivermectin PK parameters		</title>
		<link>https://burooptilt.nl/3e-blog-bericht/#comment-54</link>

		<dc:creator><![CDATA[ivermectin PK parameters]]></dc:creator>
		<pubDate>Sat, 27 Jun 2026 06:38:56 +0000</pubDate>
		<guid isPermaLink="false">https://burooptilt.nl/?p=195#comment-54</guid>

					<description><![CDATA[&lt;strong&gt;ivermectin PK parameters&lt;/strong&gt;

ivermectin PK parameters]]></description>
			<content:encoded><![CDATA[<p><strong>ivermectin PK parameters</strong></p>
<p>ivermectin PK parameters</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Reactie op 2e blog bericht door ivermectin anti‑inflammatory mechanism		</title>
		<link>https://burooptilt.nl/2e-blog-bericht/#comment-53</link>

		<dc:creator><![CDATA[ivermectin anti‑inflammatory mechanism]]></dc:creator>
		<pubDate>Fri, 26 Jun 2026 14:19:29 +0000</pubDate>
		<guid isPermaLink="false">https://burooptilt.nl/?p=194#comment-53</guid>

					<description><![CDATA[&lt;strong&gt;ivermectin anti‑inflammatory mechanism&lt;/strong&gt;

ivermectin anti‑inflammatory mechanism]]></description>
			<content:encoded><![CDATA[<p><strong>ivermectin anti‑inflammatory mechanism</strong></p>
<p>ivermectin anti‑inflammatory mechanism</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
